Boehringer Ingelheim Maintains its Growth Path in 2008, Again Growing Faster Than the Pharmaceutical Market - Major Investments Once Again in Research and Development - Good Outlook for Further Growth in 2009
21st April 2009 BRACKNELL, England, April 21 /PRNewswire/ -- Boehringer Ingelheim maintained its growth path in 2008 too, thereby
meeting the goals it had set itself.
As the company announced at its Annual...
Publication of Shire plc's Annual Report 2008
25th March 2009 DUBLIN, March 25 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that its Annual Report and Accounts in
respect of the year ended...
Sun Pharmaceutical Industries Ltd.: A Quarter of All-Around Strong Growth Sales up 66%, Profit up 121%
28th July 2008 MUMBAI, India, July 28 /PRNewswire/ -- Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN,
NSE:SUNPHARMA, BSE: 524715) reported a quarter of strong growth for the first
quarter...
Shire plc: IFRS Results for the Year Ending December 31, 2007
25th March 2008 BASINGSTOKE, England, March 25 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty
biopharmaceutical company announces its preliminary results prepared under
International...
2007 Another Record Year in Terms of Sales and Earnings for Gerresheimer
4th February 2008 DÜSSELDORF, Germany, February 4 /PRNewswire/ -- According to provisional figures, Gerresheimer AG has just
completed another record year. In 2007 the company achieved sales of
EUR957.7m, up by 48.1%;...
2007 Another Record Year in Terms of Sales and Earnings for Gerresheimer
4th February 2008 DÜSSELDORF, Germany, February 4 /PRNewswire/ -- According to provisional figures, Gerresheimer AG has just
completed another record year. In 2007 the company achieved sales of
EUR957.7m, up by 48.1%;...
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
